메뉴 건너뛰기




Volumn 52, Issue 5, 2011, Pages

International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; BETA LACTAM ANTIBIOTIC; CEFACLOR; CEFALEXIN; CEFDINIR; CEFPODOXIME PROXETIL; CEFTIBUTEN; CEFTRIAXONE; CEFUROXIME; CIPROFLOXACIN; COTRIMOXAZOLE; FLEROXACIN; FOSFOMYCIN; FOSFOMYCIN TROMETAMOL; GATIFLOXACIN; LEVOFLOXACIN; NITROFURANTOIN; NORFLOXACIN; OFLOXACIN; PEFLOXACIN; PIVMECILLINAM; PLACEBO; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULFADOXINE PLUS TRIMETHOPRIM; TRIMETHOPRIM; UNINDEXED DRUG;

EID: 79951831698     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciq257     Document Type: Article
Times cited : (2154)

References (61)
  • 1
    • 0033511781 scopus 로고    scopus 로고
    • Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women
    • Warren JW, Abrutyn E, Hebel JR, Johnson JR, Schaeffer AJ, Stamm WE. Guidelines. for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA). Clin Infect Dis 1999;29:745-58. (Pubitemid 30256361)
    • (1999) Clinical Infectious Diseases , vol.29 , Issue.4 , pp. 745-758
    • Warren, J.W.1    Abrutyn, E.2    Richard Hebel, J.3    Johnson, J.R.4    Schaeffer, A.J.5    Stamm, W.E.6
  • 2
    • 0037074321 scopus 로고    scopus 로고
    • National patterns in the treatment of urinary tract infections in women by ambulatory care physicians
    • Huang ES, Stafford RS. National patterns in the treatment of urinary tract infections in women by ambulatory care physicians. Archives of internal medicine 2002;162:41-7. (Pubitemid 34073399)
    • (2002) Archives of Internal Medicine , vol.162 , Issue.1 , pp. 41-47
    • Huang, E.S.1    Stafford, R.S.2
  • 3
    • 1342288921 scopus 로고    scopus 로고
    • Longer than recommended empiric antibiotic treatment of urinary tract infection in women: An avoidable waste of money
    • DOI 10.1111/j.1365-2710.2003.00537.x
    • Kahan NR, Chinitz DP, Kahan E. Longer than recommended empiric antibiotic treatment of urinary tract infection in women: an avoidable waste of money. Journal of clinical pharmacy and therapeutics 2004;29:59-63. (Pubitemid 38253538)
    • (2004) Journal of Clinical Pharmacy and Therapeutics , vol.29 , Issue.1 , pp. 59-63
    • Kahan, N.R.1    Chinitz, D.P.2    Kahan, E.3
  • 4
    • 33645467353 scopus 로고    scopus 로고
    • Current antibiotic therapy for isolated urinary tract infections in women
    • Kallen AJ, Welch HG, Sirovich BE. Current antibiotic therapy for isolated urinary tract infections in women. Archives of internal medicine 2006;166:635-9.
    • (2006) Archives of Internal Medicine , vol.166 , pp. 635-639
    • Kallen, A.J.1    Welch, H.G.2    Sirovich, B.E.3
  • 6
    • 33847673653 scopus 로고    scopus 로고
    • Evaluating guidelines
    • DOI 10.1086/511878
    • Stamm WE. Evaluating guidelines. Clin Infect Dis 2007;44:775-6. (Pubitemid 46365299)
    • (2007) Clinical Infectious Diseases , vol.44 , Issue.6 , pp. 775-776
    • Stamm, W.E.1
  • 7
    • 0030791388 scopus 로고    scopus 로고
    • Fosfomycin for urinary tract infections, PMID: 9255237
    • Fosfomycin for urinary tract infections. Med Lett Drugs Ther 1997;39:66-8. PMID: 9255237.
    • (1997) Med. Lett. Drugs Ther. , vol.39 , pp. 66-68
  • 8
    • 0037260436 scopus 로고    scopus 로고
    • An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: The ECO.SENS project
    • DOI 10.1093/jac/dkg028
    • Kahlmeter G. An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: the ECO. SENS Project. J Antimicrob Chemother 2003;51:69-76. (Pubitemid 36163829)
    • (2003) Journal of Antimicrobial Chemotherapy , vol.51 , Issue.1 , pp. 69-76
    • Kahlmeter, G.1
  • 9
    • 0141758347 scopus 로고    scopus 로고
    • Prevalence and antimicrobial susceptibility of pathogens in uncomplicated cystitis in Europe. The ECO. SENS study
    • Kahlmeter G. Prevalence and antimicrobial susceptibility of pathogens in uncomplicated cystitis in Europe. The ECO. SENS study. Int J Antimicrob Agents 2003;22(Suppl. 2): 49):49-52.
    • (2003) Int. J. Antimicrob. Agents , vol.22 , Issue.2 SUPPL. , pp. 49-52
    • Kahlmeter, G.1
  • 10
    • 54249101741 scopus 로고    scopus 로고
    • Surveillance study in Europe and Brazil on clinical aspects and Antimicrobial Resistance Epidemiology in Females with Cystitis (ARESC): Implications for empiric therapy
    • Naber KG, Schito G, Botto H, Palou J, Mazzei T. Surveillance study in Europe and Brazil on clinical aspects and Antimicrobial Resistance Epidemiology in Females with Cystitis (ARESC): implications for empiric therapy. Eur Urol 2008;54:1164-75.
    • (2008) Eur. Urol. , vol.54 , pp. 1164-1175
    • Naber, K.G.1    Schito, G.2    Botto, H.3    Palou, J.4    Mazzei, T.5
  • 11
    • 33747325623 scopus 로고    scopus 로고
    • Antibiotic resistance in Escherichia coli outpatient urinary isolates: Final results from the North American urinary tract infection collaborative alliance (NAUTICA)
    • Zhanel GG, Hisanaga TL, Laing NM, et al. Antibiotic resistance in Escherichia coli outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA). Int J Antimicrob Agents 2006;27:468-75.
    • (2006) Int. J. Antimicrob. Agents , vol.27 , pp. 468-475
    • Zhanel, G.G.1    Hisanaga, T.L.2    Laing, N.M.3
  • 12
    • 77950260534 scopus 로고    scopus 로고
    • Little evidence for reversibility of trimethoprim resistance after a drastic reduction in trimethoprim use
    • Sundqvist M, Geli P, Andersson DI, et al. Little evidence for reversibility of trimethoprim resistance after a drastic reduction in trimethoprim use. J Antimicrob Chemother 2010;65:350-60.
    • (2010) J. Antimicrob. Chemother. , vol.65 , pp. 350-360
    • Sundqvist, M.1    Geli, P.2    Andersson, D.I.3
  • 13
    • 0037090334 scopus 로고    scopus 로고
    • Prevalence and predictors of trimethoprim-sulfamethoxazole resistance among uropathogenic Escherichia coli isolates in Michigan
    • DOI 10.1086/339491
    • Brown PD, Freeman A, Foxman B. Prevalence and predictors of trimethoprim-sulfamethoxazole resistance among uropathogenic Escherichia coli isolates in Michigan. Clin Infect Dis 2002;34:1061-6. (Pubitemid 34289678)
    • (2002) Clinical Infectious Diseases , vol.34 , Issue.8 , pp. 1061-1066
    • Brown, P.D.1    Freeman, A.2    Foxman, B.3
  • 14
    • 0242515959 scopus 로고    scopus 로고
    • Prior antimicrobial drug exposure: A risk factor for trimethoprim- sulfamethoxazole-resistant urinary tract infections
    • DOI 10.1093/jac/dkg146
    • Metlay JP, Strom BL, Asch DA. Prior antimicrobial drug exposure: a risk factor for trimethoprim-sulfamethoxazole-resistant urinary tract infections. J Antimicrob Chemother 2003;51:963-70. (Pubitemid 36503430)
    • (2003) Journal of Antimicrobial Chemotherapy , vol.51 , Issue.4 , pp. 963-970
    • Metlay, J.P.1    Strom, B.L.2    Asch, D.A.3
  • 16
    • 40549090897 scopus 로고    scopus 로고
    • Risk factors for trimethoprim-sulfamethoxazole resistance in patients with acute uncomplicated cystitis
    • DOI 10.1128/AAC.01200-07
    • Colgan R, Johnson JR, Kuskowski M, Gupta K. Risk factors for trimethoprim-sulfamethoxazole resistance in patients with acute uncomplicated cystitis. Antimicrob Agents Chemother 2008;52:846-51. (Pubitemid 351358361)
    • (2008) Antimicrobial Agents and Chemotherapy , vol.52 , Issue.3 , pp. 846-851
    • Colgan, R.1    Johnson, J.R.2    Kuskowski, M.3    Gupta, K.4
  • 17
    • 53149119591 scopus 로고    scopus 로고
    • Emergence of fluoroquinolone resistance in outpatient urinary Escherichia coli isolates
    • Johnson L, Sabel A, Burman WJ, et al. Emergence of fluoroquinolone resistance in outpatient urinary Escherichia coli isolates. Am J Med 2008;121:876-84.
    • (2008) Am. J. Med. , vol.121 , pp. 876-884
    • Johnson, L.1    Sabel, A.2    Burman, W.J.3
  • 18
    • 53349095369 scopus 로고    scopus 로고
    • Prevalence and risk factor analysis of trimethoprim-sulfamethoxazoleand fluoroquinolone-resistant Escherichia coli infection among emergency department patients with pyelonephritis
    • Talan DA, Krishnadasan A, Abrahamian FM, Stamm WE, Moran GJ. Prevalence and risk factor analysis of trimethoprim-sulfamethoxazoleand fluoroquinolone-resistant Escherichia coli infection among emergency department patients with pyelonephritis. Clin Infect Dis 2008;47:1150-8.
    • (2008) Clin. Infect. Dis. , vol.47 , pp. 1150-1158
    • Talan, D.A.1    Krishnadasan, A.2    Abrahamian, F.M.3    Stamm, W.E.4    Moran, G.J.5
  • 19
    • 3442892932 scopus 로고    scopus 로고
    • Treatment of uncomplicated urinary tract infections in an era of increasing antimicrobial resistance
    • quiz 1053-4
    • Miller LG, Tang AW. Treatment of uncomplicated urinary tract infections in an era of increasing antimicrobial resistance. Mayo Clin Proc 2004;79:1048-53; quiz 1053-4.
    • (2004) Mayo Clin. Proc. , vol.79 , pp. 1048-1053
    • Miller, L.G.1    Tang, A.W.2
  • 20
    • 0037595456 scopus 로고    scopus 로고
    • Emerging antibiotic resistance in urinary tract pathogens
    • DOI 10.1016/S0891-5520(03)00006-0
    • Gupta K. Emerging antibiotic resistance in urinary tract pathogens. Infect Dis Clin North Am 2003;17:243-59. (Pubitemid 36760182)
    • (2003) Infectious Disease Clinics of North America , vol.17 , Issue.2 , pp. 243-259
    • Gupta, K.1
  • 22
    • 2442657715 scopus 로고    scopus 로고
    • "Collateral damage" from cephalosporin or quinolone antibiotic therapy
    • DOI 10.1086/382690
    • Paterson DL. "Collateral damage" from cephalosporin or quinolone antibiotic therapy. Clin Infect Dis 2004;38(Suppl. 4): S341-5. (Pubitemid 38669889)
    • (2004) Clinical Infectious Diseases , vol.38 , Issue.SUPPL. 4
    • Paterson, D.L.1
  • 23
    • 33645788333 scopus 로고    scopus 로고
    • Extended-spectrum β-lactamases and clinical outcomes: Current data
    • Ramphal R, Ambrose PG. Extended-spectrum β-lactamases and clinical outcomes: current data. Clin Infect Dis 2006;42(Suppl. 4): S164-72.
    • (2006) Clin. Infect. Dis. , vol.42 , Issue.4 SUPPL.
    • Ramphal, R.1    Ambrose, P.G.2
  • 24
    • 0141535257 scopus 로고    scopus 로고
    • Pivmecillinam-therapy of choice for lower urinary tract infection
    • Graninger W. Pivmecillinam-therapy of choice for lower urinary tract infection. Int J Antimicrob Agents 2003;22(Suppl. 2): 73):73-8.
    • (2003) Int. J. Antimicrob. Agents , vol.22 , Issue.2 SUPPL. , pp. 73-78
    • Graninger, W.1
  • 25
    • 0025977919 scopus 로고
    • Influence of fosfomycin on the intestinal and pharyngeal flora of man
    • Knothe H, Schafer V, Sammann A, Shah PM. Influence of fosfomycin on the intestinal and pharyngeal flora of man. Infection 1991;19:18-20.
    • (1991) Infection , vol.19 , pp. 18-20
    • Knothe, H.1    Schafer, V.2    Sammann, A.3    Shah, P.M.4
  • 26
    • 0030809280 scopus 로고    scopus 로고
    • Effect of norfloxacin, trimethoprim-sulfamethoxazole and nitrofurantoin on fecal flora of women with recurrent urinary tract infections
    • Mavromanolakis E, Maraki S, Samonis G, Tselentis Y. Effect of norfloxacin, trimethoprim-sulfamethoxazole and nitroffurantoin on fecal flora of women with recurrent urinary tract infections. J Chemother 1997;9:203-7. (Pubitemid 27288410)
    • (1997) Journal of Chemotherapy , vol.9 , Issue.3 , pp. 203-207
    • Mavromanolakis, E.1    Maraki, S.2    Samonis, G.3    Tselentis, Y.4    Cranidis, A.5
  • 27
    • 0035468838 scopus 로고    scopus 로고
    • Effect of antimicrobial agents on the ecological balance of human microflora
    • DOI 10.1016/S1473-3099(01)00066-4, PII S1473309901000664
    • Sullivan A, Edlund C, Nord C. Effect of antimicrobial agents on the ecological balance of human microflora. Lancet Infect Dis 2001;1:101-14. (Pubitemid 33586045)
    • (2001) Lancet Infectious Diseases , vol.1 , Issue.2 , pp. 101-114
    • Sullivan, A.1
  • 29
    • 33847242164 scopus 로고    scopus 로고
    • Clinical and bacteriological outcome of different doses and duration of pivmecillinam compared with placebo therapy of uncomplicated lower urinary tract infection in women: The LUTIW project
    • Ferry SA, Holm SE, Stenlund H, Lundholm R, Monsen TJ. Clinical and bacteriological outcome of different doses and duration of pivmecillinam compared with placebo therapy of uncomplicated lower urinary tract infection in women: the LUTIW project. Scand J Prim Health Care 2007;25:49-57.
    • (2007) Scand. J. Prim Health Care , vol.25 , pp. 49-57
    • Ferry, S.A.1    Holm, S.E.2    Stenlund, H.3    Lundholm, R.4    Monsen, T.J.5
  • 31
    • 0010558947 scopus 로고
    • Institute of medicine committee to advise the public health service on clinical practice guidelines
    • eds, Washington, DC: National Academy Press
    • Field MJ, Lohr KN, eds. Institute of Medicine Committee to Advise the Public Health Service on Clinical Practice Guidelines. Clinical practice guidelines: directions for a new program. Washington, DC: National Academy Press, 1990;55-77.
    • (1990) Clinical Practice Guidelines: Directions for A New Program , pp. 55-77
    • Field, M.J.1    Lohr, K.N.2
  • 32
    • 0018569077 scopus 로고
    • The periodic health examination
    • Canadian Task Force on the Periodic Health Examination
    • Canadian Task Force on the Periodic Health Examination. The periodic health examination. Can Med Assoc J 1979;121(9) ; 1193-254.
    • (1979) Can. Med. Assoc. J , vol.121 , Issue.9 , pp. 1193-1254
  • 33
    • 0031944261 scopus 로고    scopus 로고
    • Efficacy and safety of norfloxacin 800 mg once-daily versus norfloxacin 400 mg twice-daily in the treatment of uncomplicated urinary tract infections in women: A double-blind, randomized clinical trial
    • Pimentel FL, Dolgner A, Guimaraes J, Quintas M, Mario-Reis J. Efficacy and safety of norfloxacin 800 mg once-daily versus norfloxacin 400 mg twice-daily in the treatment of uncomplicated urinary tract infections in women: a double-blind, randomized clinical trial. J Chemother 1998;10:122-7. (Pubitemid 28191105)
    • (1998) Journal of Chemotherapy , vol.10 , Issue.2 , pp. 122-127
    • Pimentel, F.L.1    Dolgner, A.2    Guimaraes, J.3    Quintas, M.4    Mario-Reis, J.5
  • 34
    • 79951815470 scopus 로고    scopus 로고
    • Guidelines on urological infections
    • EAU Guidelines Edition Presented At Barcelona ISBN 978-90-79754-70-0
    • Grabe M, Bishop MC, Bjerklund-Johansen TE, et al. Guidelines on urological infections. In EAU Guidelines edition presented at the 25th EAU Annual Congress, Barcelona 2010. ISBN 978-90-79754-70-0.
    • (2010) The 25th EAU Annual Congress
    • Grabe, M.1    Bishop, M.C.2    Bjerklund-Johansen, T.E.3
  • 36
    • 36148977902 scopus 로고    scopus 로고
    • Short-course nitrofurantoin for the treatment of acute uncomplicated cystitis in women
    • DOI 10.1001/archinte.167.20.2207
    • Gupta K, Hooton TM, Roberts PL, Stamm WE. Short-course nitrofurantoin for the treatment of acute uncomplicated cystitis in women. Arch Intern Med 2007;167:2207-12. (Pubitemid 350106740)
    • (2007) Archives of Internal Medicine , vol.167 , Issue.20 , pp. 2207-2212
    • Gupta, K.1    Hooton, T.M.2    Roberts, P.L.3    Stamm, W.E.4
  • 37
    • 0033016189 scopus 로고    scopus 로고
    • A trial comparing low-dose, short-course ciprofloxacin and standard 7 day therapy with co-trimoxazole or nitrofurantoin in the treatment of uncomplicated urinary tract infection
    • Iravani A, Klimberg I, Briefer C, Munera C, Kowalsky SF, Echols RM. A trial comparing low-dose, short-course ciprofloxacin and standard 7 day therapy with co-trimoxazole or nitrofurantoin in the treatment of uncomplicated urinary tract infection. J Antimicrob Chemother 1999;43(Suppl A): 67-75. (Pubitemid 29123504)
    • (1999) Journal of Antimicrobial Chemotherapy , vol.43 , Issue.SUPPL. A , pp. 67-75
    • Iravani, A.1    Klimberg, I.2    Briefer, C.3    Munera, C.4    Kowalsky, S.F.5    Echols, R.M.6
  • 39
    • 0032796432 scopus 로고    scopus 로고
    • Comparison of single-dose fosfomycin and a 7-day course of nitrofurantoin in female patients with uncomplicated urinary tract infection
    • Stein GE. Comparison of single-dose fosfomycin and a 7-day course of nitrofurantoin in female patients with uncomplicated urinary tract infection. Clin Ther 1999;21:1864-72.
    • (1999) Clin. Ther. , vol.21 , pp. 1864-1872
    • Stein, G.E.1
  • 40
    • 0032052545 scopus 로고    scopus 로고
    • A comparison between single-dose fosfomycin trometamol (Monuril∞) and a 5-day course of trimethoprim in the treatment of uncomplicated lower urinary tract infection in women
    • DOI 10.1016/S0924-8579(98)00021-1, PII S0924857998000211
    • Minassian MA, Lewis DA, Chattopadhyay D, Bovill B, Duckworth GJ, Williams JD. A comparison between single-dose fosfomycin trometamol (Monuril) and a 5-day course of trimethoprim in the treatment of uncomplicated lower urinary tract infection in women. Int J Antimicrob Agents 1998;10:39-47. (Pubitemid 28234359)
    • (1998) International Journal of Antimicrobial Agents , vol.10 , Issue.1 , pp. 39-47
    • Minassian, M.A.1    Lewis, D.A.2    Chattopadhyay, D.3    Bovill, B.4    Duckworth, G.J.5    Williams, J.D.6
  • 42
    • 52649112236 scopus 로고    scopus 로고
    • Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli
    • Rodriguez-Bano J, Alcala JC, Cisneros JM, et al. Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli. Arch Intern Med 2008;168:1897-02.
    • (2008) Arch. Intern. Med. , vol.168 , pp. 1897-1802
    • Rodriguez-Bano, J.1    Alcala, J.C.2    Cisneros, J.M.3
  • 43
    • 0035990769 scopus 로고    scopus 로고
    • Three days of pivmecillinam or norfloxacin for treatment of acute uncomplicated urinary infection in women
    • Nicolle LE, Madsen KS, Debeeck GO, et al. Three days of pivmecillinam or norfloxacin for treatment of acute uncomplicated urinary infection in women. Scand J Infect Dis 2002;34:487-92.
    • (2002) Scand. J. Infect. Dis. , vol.34 , pp. 487-492
    • Nicolle, L.E.1    Madsen, K.S.2    Debeeck, G.O.3
  • 45
    • 0032766826 scopus 로고    scopus 로고
    • Comparison of sparfloxacin and ciprofloxacin in the treatment of community-acquired acute uncomplicated urinary tract infection in women
    • DOI 10.1016/S0149-2918(99)80018-6
    • Henry DC, Nenad RC, Iravani A, et al. Comparison of sparfloxacin and ciprofloxacin in the treatment of community-acquired acute uncomplicated urinary tract infection in women. parfloxacin Multicenter Uncomplicated Urinary Tract Infection Study Group. Clin Ther 1999;21:966-81. (Pubitemid 29326157)
    • (1999) Clinical Therapeutics , vol.21 , Issue.6 , pp. 966-981
    • Henry, D.C.1    Nenad, R.C.2    Iravani, A.3    Tice, A.D.4    Mansfield, D.L.5    Magner, D.J.6    Dorr, M.B.7    Talbot, G.H.8
  • 47
    • 0036184901 scopus 로고    scopus 로고
    • Single-dose fluoroquinolone therapy of acute uncomplicated urinary tract infection in women: Results from a randomized, double-blind, multicenter trial comparing single-dose to 3-day fluoroquinolone regimens
    • DOI 10.1016/S0090-4295(01)01562-X, PII S009042950101562X
    • Richard GA, Mathew CP, Kirstein JM, Orchard D, Yang JY. Single-dose fluoroquinolone therapy of acute uncomplicated urinary tract infection in women: results from a randomized, double-blind, multicenter trial comparing single-dose to 3-day fluoroquinolone regimens. Urology 2002;59:334-9. (Pubitemid 34189729)
    • (2002) Urology , vol.59 , Issue.3 , pp. 334-339
    • Richard, G.A.1    Mathew, C.P.2    Kirstein, J.M.3    Orchard, D.4    Yang, J.Y.5
  • 48
    • 25844442538 scopus 로고    scopus 로고
    • Efficacy and safety of a novel once-daily extended-release ciprofloxacin tablet formulation for treatment of uncomplicated urinary tract infection in women
    • DOI 10.1128/AAC.49.10.4137-4143.2005
    • Fourcroy JL, Berner B, Chiang YK, Cramer M, Rowe L, Shore N. Efficacy and safety of a novel once-daily extended-release ciprofloxacin tablet formulation for treatment of uncomplicated urinary tract infection in women. Antimicrob Agents Chemother 2005;49:4137-43. (Pubitemid 41400956)
    • (2005) Antimicrobial Agents and Chemotherapy , vol.49 , Issue.10 , pp. 4137-4143
    • Fourcroy, J.L.1    Berner, B.2    Chiang, Y.-K.3    Cramer, M.4    Rowe, L.5    Shore, N.6
  • 49
    • 0036931775 scopus 로고    scopus 로고
    • Comparison of once-daily extended-release ciprofloxacin and conventional twice-daily ciprofloxacin for the treatment of uncomplicated urinary tract infection in women
    • DOI 10.1016/S0149-2918(02)80099-6
    • Henry DC Jr, Bettis RB, Riffer E, et al. Comparison of oncedaily extended-release ciprofloxacin and conventional twice-daily ciprofloxacin for the treatment of uncomplicated urinary tract infection in women. Clin Ther 2002;24:2088-104. (Pubitemid 36051533)
    • (2002) Clinical Therapeutics , vol.24 , Issue.12 , pp. 2088-2104
    • Henry Jr., D.C.1    Bettis, R.B.2    Riffer, E.3    Haverstock, D.C.4    Kowalsky, S.F.5    Manning, K.6    Hamed, K.A.7    Church, D.A.8
  • 50
    • 1442360078 scopus 로고    scopus 로고
    • Optimal duration of antibiotic therapy for uncomplicated urinary tract infection in older women: A double-blind randomized controlled trial
    • Vogel T, Verreault R, Gourdeau M, Morin M, Grenier-Gosselinl L, Rochette L. Optimal duration of antibiotic therapy for uncomplicated urinary tract infection in older women: a double-blind randomized controlled trial. CMAJ 2004;170:469-73. (Pubitemid 38293641)
    • (2004) Canadian Medical Association Journal , vol.170 , Issue.4 , pp. 469-473
    • Vogel, T.1    Verreault, R.2    Gourdeau, M.3    Morin, M.4    Grenier-Gosselin, L.5    Rochette, L.6
  • 51
    • 18544387783 scopus 로고    scopus 로고
    • Single-dose ciprofloxacin versus 3 days of norfloxacin in uncomplicated urinary tract infections in women
    • DOI 10.1046/j.1198-743x.2001.00359.x
    • Auquer F, Cordon F, Gorina E, Caballero JC, Adalid C, Batlle J. Singledose ciprofloxacin versus 3 days of norfloxacin in uncomplicated urinary tract infections in women. Clin Microbiol Infect 2002;8:50-4. (Pubitemid 34993761)
    • (2002) Clinical Microbiology and Infection , vol.8 , Issue.1 , pp. 50-54
    • Auquer, F.1    Cordon, F.2    Gorina, E.3    Caballero, J.C.4    Adalid, C.5    Batlle, J.6
  • 53
    • 3042793159 scopus 로고    scopus 로고
    • Acute uncomplicated cystitis in an Era of increasing antibiotic resistance: A proposed approach to empirical therapy
    • DOI 10.1086/422145
    • Hooton TM, Besser R, Foxman B, Fritsche TR, Nicolle LE. Acute uncomplicated cystitis in an era of increasing antibiotic resistance: a proposed approach to empirical therapy. Clin Infect Dis 2004;39:75-80. (Pubitemid 38879552)
    • (2004) Clinical Infectious Diseases , vol.39 , Issue.1 , pp. 75-80
    • Hooton, T.M.1    Besser, R.2    Foxman, B.3    Fritsche, T.R.4    Nicolle, L.E.5
  • 54
    • 0033870179 scopus 로고    scopus 로고
    • Cefdinir versus cefaclor in the treatment of uncomplicated urinary tract infection
    • DOI 10.1016/S0149-2918(00)80054-5
    • Leigh AP, Nemeth MA, Keyserling CH, Hotary LH, Tack KJ. Cefdinir versus cefaclor in the treatment of uncomplicated urinary tract infection. Clin Ther 2000;22:818-25. (Pubitemid 30625914)
    • (2000) Clinical Therapeutics , vol.22 , Issue.7 , pp. 818-825
    • Leigh, A.P.1    Anne Nemeth, M.2    Keyserling, C.H.3    Hotary, L.H.4    Tack, K.J.5
  • 56
    • 38649143127 scopus 로고    scopus 로고
    • A Double-Blind, Randomized Comparison of Levofloxacin 750 mg Once-Daily for Five Days With Ciprofloxacin 400/500 mg Twice-Daily for 10 Days for the Treatment of Complicated Urinary Tract Infections and Acute Pyelonephritis
    • DOI 10.1016/j.urology.2007.09.002, PII S0090429507021139
    • Peterson J, Kaul S, Khashab M, Fisher AC, Kahn JB. A double-blind, randomized comparison of levofloxacin 750 mg once-daily for five days with ciprofloxacin 400/500 mg twice-daily for 10 days for the treatment of complicated urinary tract infections and acute pyelonephritis. Urology 2008;71:17-22. (Pubitemid 351173271)
    • (2008) Urology , vol.71 , Issue.1 , pp. 17-22
    • Peterson, J.1    Kaul, S.2    Khashab, M.3    Fisher, A.C.4    Kahn, J.B.5
  • 57
    • 0346499059 scopus 로고    scopus 로고
    • Once daily, extended release ciprofloxacin for complicated urinary tract infections and acute uncomplicated pyelonephritis
    • DOI 10.1097/01.ju.0000106191.11936.64
    • Talan DA, Klimberg IW, Nicolle LE, Song J, Kowalsky SF, Church DA. Once daily, extended release ciprofloxacin for complicated urinary tract infections and acute uncomplicated pyelonephritis. J Urol 2004;171:734-9. (Pubitemid 38090470)
    • (2004) Journal of Urology , vol.171 , Issue.2 , pp. 734-739
    • Talan, D.A.1    Klimberg, I.W.2    Nicolle, L.E.3    Song, J.4    Kowalsky, S.F.5    Church, D.A.6
  • 60
    • 0036149661 scopus 로고    scopus 로고
    • Short-term effectiveness of ceftriaxone single dose in the initial treatment of acute uncomplicated pyelonephritis in women. A randomised controlled trial
    • Sanchez M, Collvinent B, Miro O, et al. Short-term effectiveness of ceftriaxone single dose in the initial treatment of acute uncomplicated pyelonephritis in women: a randomised controlled trial. Emerg Med J 2002;19:19-22. (Pubitemid 34092531)
    • (2002) Emergency Medicine Journal , vol.19 , Issue.1 , pp. 19-22
    • Sanchez, M.1    Collvinent, B.2    Miro, O.3    Horcajada, J.P.4    Moreno, A.5    Marco, F.6    Mensa, J.7    Milla, J.8
  • 61
    • 34547138656 scopus 로고    scopus 로고
    • Population-based epidemiologic analysis of acute pyelonephritis
    • DOI 10.1086/519268
    • Czaja CA, Scholes D, Hooton TM, Stamm WE. Population-based epidemiologic analysis of acute pyelonephritis. Clin Infect Dis 2007;45:273-80. (Pubitemid 47101021)
    • (2007) Clinical Infectious Diseases , vol.45 , Issue.3 , pp. 273-280
    • Czaja, C.A.1    Scholes, D.2    Hooton, T.M.3    Stamm, W.E.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.